Prescient Therapeutics Limited

PTX

Prescient Therapeutics Ltd. is a biopharmaceutical company, which engages in the discovery and development of novel immunotherapeutic products for the treatment of chronic infectious diseases and cancer. The company is headquartered in South Melbourne, Victoria. The firm is developing personalized medicine approaches to cancer, including targeted and cellular therapies. Its product pipeline includes PTX-100, PTX-200, OmniCAR, CellPryme-M and CellPryme-A. PTX-100 has completed Phase Ib expansion cohort study in relapsed and refractory T cell lymphomas. PTX-200 is a PH domain inhibitor that inhibits a tumor survival pathway, Akt. OmniCAR is a universal immune receptor platform being developed to enable controllable T-cell activity and multi-antigen targeting with a single-cell product. CellPryme-M technology enhances adoptive cell therapy performance by shifting T and NK cells towards a central memory phenotype, improving persistence, and increasing the ability to find and penetrate tumors. CellPryme-A is an adjuvant therapy designed to be administered to patients alongside cellular immunotherapy to help them overcome a suppressive tumor microenvironment.

Platinum Asset Management Limited

PTM

Platinum Asset Management Ltd. is a non-operating holding company, which engages in the provision of financial services. The company is headquartered in Sydney, New South Wales. The company went IPO on 2007-05-23. The firm is engaged in the fund management business. The company operates through two segments: funds management and investments and other. Its products by type include Managed Funds, Listed Investment Companies, Active Exchange Traded Managed Funds (ETMFs), mFund, Platinum Investment Bond and Offshore Products. Its managed funds include Platinum International Fund, Platinum Global Fund, Platinum Asia Fund, Platinum European Fund, Platinum Japan Fund, Platinum International Brands Fund, Platinum International Health Sciences Fund, Platinum International Technology Fund, MLC Platinum Global Fund, and Platinum Global Transition Fund. The mFund Settlement Service allows access to certain unlisted managed funds through a more streamlined transaction settlement process. Active ETMFs offer investors the advantage of knowing the fund’s intra-day indicative NAV per unit before placing a trade.

Patronus Resources Limited

PTN

Patronus Resources Ltd is a AU-based company operating in Metals & Mining industry. The company is headquartered in Perth, Western Australia. The company went IPO on 2013-10-02. Patronus Resources Limited, formerly Kin Mining NL, is an Australia-based gold development and exploration company. The firm is focused on its 100% owned Cardinia Gold Project (CGP) located in the prospective north-eastern Goldfields region of Western Australia. The CGP has a 1.4 million ounces (Moz) gold mineral resource. The firm's projects include Raeside, Randwick, Mt Flora, Murrin Murrin, Redcastle, Desdemona, Iron King Group, Mt Fouracre, Hayes Creek, Fountain Head and Thunderball Uranium. The Raeside project consists of two tenements, M37/1298 (11.2 square kilometers) and E37/1300 (12.0 square kilometers), located approximately 10 kilometers (km) east of Leonora. The Randwick Gold project is a greenfield project area (28.2 square kilometers) that has been identified for its gold and base metal potential. The Mt Flora project consists of three contiguous tenements, M39/1118, P39/5859 and P39/5860, covering an area of (12.82 square kilometers).